Reappraisal of pancreas transplantation. Issue 7 (July 2019)

• Record Type: Journal Article
• Authors: Shyr, Yi-Ming; Wang, Shin-E; Chen, Shih-Chin; Shyr, Bor-Uei
• Is Part Of: Journal of the Chinese Medical Association. Volume 82:Issue 7(2019)
• Publication Date: 2019-07
• Subjects: Pancreas transplantation -- Simultaneous pancreas and kidney transplantation -- Type 1 diabetes mellitus; Medicine -- Periodicals; 610.5
• DOI: 10.1097/JCMA.0000000000000122
• Languages: English
• ISSNs: 1726-4901

Abstract

Abstract : Pancreas transplantation is currently the most effective and curative treatment for complicated type 1 diabetes mellitus, providing durable and physiological insulin-independent euglycemia, preventing worsening or ameliorating of diabetic complications, and improving quality of life. Currently, more than 31 000 pancreas transplantation procedures have been performed, mainly in the United States. Pancreas transplantation is still an uncommon procedure in Asia, mainly performed in Korea, Taiwan, and Japan. The first pancreas (simultaneous pancreas and kidney transplantation) transplantation was successfully initiated at Taipei Veterans General Hospital on September 19, 2003, and we are the first team to be qualified to perform human pancreas procurement and transplantation by Taiwan Department of Health on August 31, 2007. The technique success rate in our pancreas transplantation is 97%, with 1-year pancreas graft survival rate of 95.8%, 5-year pancreas graft survival rate of 89.9%, and 10-year pancreas graft survival rate of 65.9%.